352-353 / 1816
15 fractions
2.4Gy
2.7Gy
3.2Gy
IMPORT HIGH trial
•
2,600 patients – in follow up
•
Tailor dose across breast according
to risk of relapse
•
Uses complex IMRT & IGRT
•
Secondary endpoints of normal
tissue toxicity will report 2018